• Skip to main content
  • Skip to primary sidebar

Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep

Asia Food Journal
  • Home
  • Latest News
  • Channels
    • Packaging
    • Processing
    • Ingredients
    • Industry
    • Automation
    • Guest Posts
    • Market Trends
  • Subscribe
  • Advertise
  • Event Calendar
  • Contact Us
    • Submit Guest Posts
Share
Leaderboard of Asia Food Journal




Blue California completes groundbreaking human clinical trial on ErgoActive® ergothioneine intervention for cognitive function, memory, and sleep

February 6, 2024 by Cath Isabedra

ergoactive ergothioneine

Courtesy of Blue California

Rancho Santa Margarita, Calif., Feb 06, 2024 (GLOBE NEWSWIRE) — Blue California, an industry leader in science-driven ingredient development, announced the successful completion of a groundbreaking human clinical trial of ergothioneine. A double-blinded placebo-controlled clinical trial sponsored by Blue California has shown that ErgoActive® ergothioneine supports aspects of cognitive function, memory, and sleep in healthy elderly subjects with subjective memory complaints. 

“Blue California is proud to have sponsored such an important human study,” said Linda May-Zhang, Ph.D., VP of Science and Innovation at Blue California. “We are pleased by the results showing improvements of cognitive function and ability to get to sleep in subjects consuming ErgoActive for four months.” 

Leaderboard of Asia Food Journal

Research has suggested that inadequate levels of ergothioneine are associated with a range of health problems, including cardiovascular disease, frailty, age-related cognitive decline, neurodegenerative diseases such as Parkinson’s disease, and dementias such as Alzheimer’s disease. Mushroom consumption and estimated dietary ergothioneine intake have previously been associated with reduced risk of cognitive decline and potentially longer lifespan. 

Despite decades of preclinical research, association studies, and clinical studies conducted with mushrooms, it remained untested whether supplementation with pure ergothioneine can improve cognitive outcomes. Rigorous clinical studies were lacking. Today, Blue California has substantially advanced by sponsoring a double-blinded, placebo-controlled clinical study conducted at a national research institution. 

Sharing his insights, Robert B. Beelman, Ph.D., Professor Emeritus of Food Science and Director of the Center for Plant and Mushroom Foods for Health at Pennsylvania State University, stated, “The results of this study provide important clinical evidence supporting the idea that ergothioneine is a ‘longevity vitamin’ that can help mitigate cognitive decline and sleep issues commonly associated with aging.” 

Blue California is a proud gold sponsor for the National University of Singapore’s Center of Healthy Longevity global conference on Supplements for Healthy Longevity, held Feb. 29 – Mar. 2, 2024. 

ErgoActive ergothioneine is made by precision fermentation with FDA-reviewed safety of GRAS. This ingredient is easy to formulate for dietary supplements, functional food and beverages, pet supplements, and cosmetics.

###

About Blue California Ingredients

Blue California is a science-driven, nature-inspired ingredient company dedicated to developing innovative solutions for health and well-being. We provide and manufacture clean, natural, and sustainable ingredients used in food, beverage, flavor, fragrance, dietary supplements, personal care, and cosmetic products.

With a commitment to rigorous scientific research, the company aims to address pressing concerns related to aging and healthspan.  For more information, visit https://bluecal-ingredients.com/ergothioneine.

ErgoActive® is a registered trademark of Blue California, Inc.

Ergothioneine is also referred to as L-Ergothioneine, (ET) and (ERG).

Other Topics: Blue California, Ergoactive ergothioneine, Human Clinical trial, Industry, Ingredients

Related Articles

  • Jollibee growth

    Courtesy of Jollibee Group

    Jollibee continues stellar growth across Southeast Asia, strengthens leadership in key markets
  • HMO Regulatory Approval

    Courtesy of dsm-firmenich

    Regulatory approval for dsm-firmenich’s 2’-FL HMO ingredient in Indonesia: Safety clearance allows new market access
  • FBIF 2025

    Courtesy of FBIF

    FBIF 2025 recap: Exploring future growth of global F&B industry
  • Global online trends 2025

    Courtesy of IGD

    IGD’s Online Retail Trends Report 2025: Online grocery leading the charge as the fastest growing channel
  • Lee Kum Kee at THAIFEX 2025

    Courtesy of Lee Kum Kee

    Lee Kum Kee at THAIFEX 2025: Connecting the world through Asian culinary culture
  • Arla Foods Ingredients and Alchemy Agencies

    Courtesy of Arla Foods Ingredients

    Arla Foods Ingredients and Alchemy Agencies sign new distribution agreement
Leaderboard of Asia Food Journal

Primary Sidebar

Stay Connected

Your browser does not support the video tag. Learn More




🔥 Trending News

Blue Bottle Coffee announces opening of first Southeast Asian outlet in LUMINE
Farmlore in Bengaluru is unveiled as the winner of the American Express One to
Syensqo achieves breakthrough in mechanical recycling of PVDC multilayer
Blue Bottle Coffee announces opening of first Southeast Asian outlet in LUMINE

Trending News

Subsribe to Our News Letter

Subscribe To
Our Newsletter


By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

© 2025 Harvest Information. All rights reserved. Privacy Policy.

Become an F&B industry insider

Your go-to resource for all the latest trends, innovations, and news about the food and beverage industry!

 

By submitting this form, you consent to receive marketing emails from Asia Food Journal. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.

Disclaimer: Translations on this website are automated using Google Translate. While we strive for accuracy, please be cautious, as machine translations may contain errors. For critical or sensitive content, consider seeking professional human translation. We are not liable for any reliance on the translated content.